CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · Real-Time Price · USD

2.690

-0.510 (-15.94%)

Sep 15, 2026, 4:00 PM EDT - Market closed

CytomX Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	586	722	81	104	106	283
Market Cap Growth	77.73%	795.45%	-22.37%	-1.80%	-62.58%	-6.69%
Enterprise Value	262	584	-26	-75	-70	69
Last Close Price	2.69	4.26	1.03	1.55	1.60	4.33

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	2.53	-	-	-
Forward PE	-	3.03	47.99	16.30	-	-
PS Ratio	32.02	9.47	0.58	1.03	1.99	7.57
PB Ratio	1.94	7.29	-176.77	-2.19	-1.23	-615.53
P/TBV Ratio	1.95	7.39	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	14.29	7.66	-	-	-	1.84

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.02	0.04	-20.58	-0.29	-0.21	-47.22
Debt / EBITDA Ratio	-	-	0.29	-	-	-
Net Debt / Equity Ratio	-1.07	-1.34	200.08	3.38	2.05	617.76
Net Debt / EBITDA Ratio	3.77	7.30	-3.41	37.26	1.92	2.50
Net Debt / FCF Ratio	3.94	1.75	1.05	2.82	1.56	2.35
Asset Turnover	0.07	0.56	0.86	0.44	0.18	0.11
Quick Ratio	9.26	2.98	1.21	1.14	1.51	3.93
Current Ratio	9.36	3.09	1.25	1.17	1.55	3.99
Return on Equity (ROE)	-37.75%	-35.25%	-	-	-	-
Return on Assets (ROA)	-19.58%	-8.99%	9.69%	-1.75%	-19.54%	-20.78%
Return on Invested Capital (ROIC)	-	-4088.61%	61.56%	1.44%	-50.75%	-42.04%
Return on Capital Employed (ROCE)	-25.50%	-18.60%	71.90%	-14.10%	-86.70%	-44.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-14.10%	-2.41%	39.54%	-0.55%	-93.93%	-41.01%
FCF Yield	-14.07%	-10.50%	-107.36%	-54.78%	-106.42%	-42.70%
Buyback Yield / Dilution	-88.30%	-62.77%	-14.82%	-12.27%	-2.48%	-39.01%

SEC Filings: 10-K · 10-Q